Key result
The Nuubo biomedical shirt-based ECG monitoring system is being evaluated in a prospective observational study across four distinct cardiovascular patient cohorts, with no clinical results available as patient recruitment has not yet started.
Why the study?
Does biomedical shirt-based ECG monitoring provide clinical utility in diverse adult and pediatric cardiovascular patients?
Observational (n=220)
1:1 in the post-MI cardiac rehabilitation arm
Yes
Does biomedical shirt-based ECG monitoring provide clinical utility in diverse adult and pediatric cardiovascular patients?
This study design outlines a multicenter prospective observational study evaluating the utility of a wearable biomedical ECG shirt across diverse cardiovascular patient populations.
BACKGROUND: Today, the main challenge for researchers is to develop new technologies which may help to improve the diagnoses of cardiovascular disease (CVD), thereby reducing healthcare costs and improving the quality of life for patients. This study aims to show the utility of biomedical shirt-based electrocardiography (ECG) monitoring of patients with CVD in different clinical situations using the Nuubo® ECG (nECG) system. METHODS: An investigator-initiated, multicenter, prospective observational study was carried out in a cardiology (adult and pediatric) and cardiac rehabilitation wards. ECG monitoring was used with the biomedical shirt in the following four independent groups of patients: 1) 30 patients after pulmonary vein isolation (PVI), 2) 30 cardiac resynchronization therapy (CRT) recipients, 3) 120 patients during cardiac rehabilitation after myocardial infarction, and 4) 40 pediatric patients with supraventricular tachycardia (SVT) before electrophysiology study. Approval for all study groups was obtained from the institutional review board. The biomedical shirt captures the electrocardiographic signal via textile electrodes integrated into a garment. The software allows the visualization and analysis of data such as ECG, heart rate, arrhythmia detecting algorithm and relative position of the body is captured by an electronic device. DISCUSSION: The major advantages of the nECG system are continuous ECG monitoring during daily activities, high quality of ECG recordings, as well as assurance of a proper adherence due to adequate comfort while wearing the shirt. There are only a few studies that have examined wearable systems, especially in pediatric populations. TRIAL REGISTRATION: This study is registered in ClinicalTrials.gov: Identifier NCT03068169. (Cardiol J 2018; 25, 1: 52-59).
No takes yet. Share an insight, caveat, or question.
Balsam et al. (2017) conducted an observational in Cardiovascular disease (Atrial fibrillation, Heart failure, Myocardial infarction, Supraventricular tachycardia) (n=220). Nuubo ECG (nECG) biomedical shirt-based monitoring system vs. Standard care or unmotivated control (in the post-MI arm) was evaluated on Atrial fibrillation burden (PVI group), true BiV% (CRT group), average daily steps (MI group), and differentiation of AVNRT/AVRT (SVT group). The Nuubo biomedical shirt-based ECG monitoring system is being evaluated in a prospective observational study across four distinct cardiovascular patient cohorts, with no clinical results available as patient recruitment has not yet started.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: